versión imprimible
 
 

3rd Bacteriophage Therapy Summit 2021 - Boston, MA

Evvnt Promotion / evvnt
-
23.03.2021 - 25.03.2021  Online
Time: 08:00 - 17:00
 
Temas de la conferencia
Returning in March, the 3rd Bacteriophage Therapy Summit will discuss the characterization, pre-clinical and clinical development, formulation and manufacturing, regulation and the market delivery, this is the end-to-end specialised virtual meeting for you to translate your bacteriophage research into targeted therapeutics that demonstrate clinically significant results.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Sailaja Puttagunta, CMO, BiomX, Steven Theriault, CEO and CSO, Cytophage, Xavier Duportet, Co-Founder and CEO, Eligo Bioscience, Cara Fiore, Microbiologist, FDA, Office of Vaccines Research and Review and more.
 

Información e inscripción:

https://go.evvnt.com/709133-2?pid=4832
Mr. Customer Services
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Conference Only - Industry (Early Bird and group discounts available): USD 1949.0, Conference Only - Academic/Start-Up (Early Bird and group discounts available): USD 1499.0
Los participantes esperaban
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

European Public Health Association (EUPHA)Hilfswerk AustriaCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrztekammer für WienHelix - Forschung & Beratung WienCharité International AcademyÖsterreichisches Rotes KreuzAlumni Club Medizinische Universität Wien